» Articles » PMID: 16251329

Differential Antibiotic Susceptibilities of Starved Mycobacterium Tuberculosis Isolates

Overview
Specialty Pharmacology
Date 2005 Oct 28
PMID 16251329
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

We compared the efficacies of 17 agents against rapidly growing and starved Mycobacterium tuberculosis H37Rv. Few compounds have significant activity at attainable concentrations. However, two phenothiazine compounds at similar concentrations were bactericidal for starved and growing cells. These drugs appear to target a process important in both replicating and nonreplicating bacteria.

Citing Articles

Predicting tuberculosis drug efficacy in preclinical and clinical models from data.

Goh J, Patel A, Ngara B, Van Wijk R, Strydom N, Wang Q iScience. 2025; 28(3):111932.

PMID: 40034847 PMC: 11875147. DOI: 10.1016/j.isci.2025.111932.


Preclinical Evaluation of Selene-Ethylenelacticamides in Tuberculosis: Effects Against Active, Dormant, and Resistant and In Vitro Toxicity Investigation.

de Sousa N, de Freitas M, Sidronio M, Souza H, Czeczot A, Perello M Microorganisms. 2025; 13(2).

PMID: 40005762 PMC: 11858155. DOI: 10.3390/microorganisms13020396.


Facile metabolic reprogramming distinguishes mycobacterial adaptation to hypoxia and starvation: ketosis drives starvation-induced persistence in M. bovis BCG.

Davis N, Chionh Y, Mcbee M, Hia F, Ma D, Cui L Commun Biol. 2024; 7(1):866.

PMID: 39009734 PMC: 11250799. DOI: 10.1038/s42003-024-06562-2.


PDADMAC/Alginate-Coated Gold Nanorod For Eradication of Staphylococcus Aureus Biofilms.

Manimaran M, Teo Y, Kah J, Beishenaliev A, Loke Y, Foo Y Int J Nanomedicine. 2024; 19:3697-3714.

PMID: 38681091 PMC: 11055529. DOI: 10.2147/IJN.S452085.


Genetic factors affecting storage and utilization of lipids during dormancy in .

Sturm A, Sun P, Avila-Pacheco J, Clatworthy A, Bloom-Ackermann Z, Wuo M mBio. 2024; 15(2):e0320823.

PMID: 38236034 PMC: 10865790. DOI: 10.1128/mbio.03208-23.


References
1.
Wallis R, Patil S, Cheon S, Edmonds K, Phillips M, Perkins M . Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1999; 43(11):2600-6. PMC: 89531. DOI: 10.1128/AAC.43.11.2600. View

2.
Heifets L, Simon J, Pham V . Capreomycin is active against non-replicating M. tuberculosis. Ann Clin Microbiol Antimicrob. 2005; 4:6. PMC: 1083412. DOI: 10.1186/1476-0711-4-6. View

3.
Betts J, Lukey P, Robb L, McAdam R, Duncan K . Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002; 43(3):717-31. DOI: 10.1046/j.1365-2958.2002.02779.x. View

4.
Ordway D, Viveiros M, Leandro C, Bettencourt R, Almeida J, Martins M . Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2003; 47(3):917-22. PMC: 149316. DOI: 10.1128/AAC.47.3.917-922.2003. View

5.
Gomez J, McKinney J . M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb). 2003; 84(1-2):29-44. DOI: 10.1016/j.tube.2003.08.003. View